🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

CorMedix Inc.

CRMD Healthcare
$5.27 +$0.19 (3.74%)
Market Cap: $419.16 M
Gurus Holding
3
Popularity Rank
#2774
% of Shares Held
2.26%
Net Activity (Q3 2026)
-$4.23 M

Guru Ownership Trend

Guru Analysis for CorMedix Inc. (CRMD)

CorMedix Inc. (CRMD), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.49 M.

Top institutional holders include Chuck Royce and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.23 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Cliff Asness reduced exposure by 42.9%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$420,243
Total Buy Value
New Buys 1
Additions 0
-$4.65 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for CorMedix Inc. (CRMD)

Major holders include Chuck Royce ($12.78 M), Cliff Asness ($666,182), Renaissance Technologies (RenTech) ($420,243). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.8 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.23 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited CRMD. The total reported sell value was $4.65 M.

Yes, 1 managers opened new positions in CRMD, and 0 increased their existing holdings. The total reported buy value was $420,243.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.12% Reduce -23.7% 1,659,947 $12.78 M Q3 2026
0.00% Reduce -42.9% 86,517 $666,182 Q3 2026
0.00% New Buy 54,577 $420,243 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form